Inflammation has been established as an important determinant of cardiovascular disease
progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis,
prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify
patients in risk groups but their potential to guide treatment decisions and management of patients
has not been extensively evaluated. Therefore, in this review article we present the most recent
data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.
Keywords: Atherosclerosis, biomarkers, cardiovascular diseases, coronary artery disease, heart failure, hypertension, inflammation,
peripheral artery disease, stroke.
Rights & PermissionsPrintExport